Fund
HYPE
HYPE is a fund that invests in companies and technologies related to hype, such as personalized medicine, hyperscale data centers, hypersonic missiles, and AI-driven ERP systems.
Why it’s in the news: It is in the news now due to its involvement with Moderna's potentially overhyped personalized cancer treatment and its investment in Castelion, a hypersonic missile manufacturer.
Latest on HYPE
- Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
- US claims 15 of the world's top 20 hyperscale datacenter locations
- Castelion hits $13B valuation to mass-produce hypersonic missiles
- Hyperflow leva ERP Conversacional e inteligência artificial ao ERP Summit Brasil 2027
- Hyperscalers’ Off-Grid Power Push Comes With Risks
- HYPE jumps 11% as Trump says CFTC is working to bring Hyperliquid to U.S.
- Hyperliquid's RWA perps boom is eating into the revenue that backs HYPE
Connections
27 entities linked to HYPE across the news graph.